Navigation Links
The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
Date:12/12/2012

ts for pharma: improving clinical trial results and supporting new applications
Limiting the patient population based on genomic analysis with companion diagnostics can improve clinical trial data for a new drug and strengthen the case for regulatory approvals for use in targeted patient populations. This use of biomarkers to enhance trial results is expected to become the norm rather than the exception and may expand the use of the product by seeking a higher level of regulatory approval.



Furthermore, the use of companion diagnostics may reinvigorate interest in the back file of products that failed to jump regulatory hurdles related to efficacy in larger patient populations if it can be proven that specific patient subsets would benefit.



Benefits for payers: more assurance that money will be well spent
With a couple of notable exceptions, the rise of targeted therapies has been hampered by their relatively poor improvements in real-world therapeutic benefits relative to their sometimes eye-watering expense. The role played by pharmacoeconomics cannot be understated: health payers do not want to pay for expensive medicines unless there is confidence that the therapeutic benefit will be achieved. Companion diagnostics go a long way to providing that confidence by determining the appropriateness of a drug to a given disease state.


The challenge for regulators
The companion diagnostics market has grown very rapidly, and regulators have been running to catch up. Drug developers need clear guidance which sets out the regulatory bodies' expectations and standards for approval. So far, there has been little attempt by regulatory agencies to impose too many restrictions or enforce a parallel approval process. While this policy looks set to continue, however, we are already seeing an increase in companion diagnostic tests being stipulated as a requirement within the approval process and it may be inevitabl
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Alexza Receives Complete Response Letter for Adasuve™ NDA
2. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
3. Viztek Announces Availability of Opal-Mammo Integrated Mammography Suite - Complete Womens Health Package Combines PACS and Tracking Software
4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
5. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
6. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
7. CryoLife Completes Acquisition of Hemosphere
8. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
9. FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet
10. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
11. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... corporate image and impressive new product developments at the Special ... "After ten years of unerring focus on product literature databases ... need to mark the occasion," said founding director ... some interesting developments of benefit to our clients and what ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
(Date:5/21/2013)... 2013 iHealth Lab Inc., a pioneer ... healthcare products and a powerful integrated mobile app ... of two new fitness products to its existing ... the Wireless Pulse Oximeter and Wireless Activity and ... iHealth Lab is also excited ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... da Vinci surgery robot lawsuit is nearing its ... According to Bloomberg.com, during closing statements yesterday, an ... car dealership, alleging the company wanted to tie sales ... to do all the training to keep control of ...
(Date:5/21/2013)... 21, 2013 Today, Zane Benefits, Inc. ... FSA accounts. Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... , According to Zane Benefits’ website, the Affordable Care ... into law in 2010 and impacts many areas of ...
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 While ... is synonymous with comprehensive travel guides. Brunswick Plantation & ... golf packages that include access to 27 holes of ... golf courses in North Carolina, knowing the Top ... and Lodges takes away the overwhelming task of selecting ...
(Date:5/21/2013)... Octo Consulting Group, an award-winning provider ... to the Federal marketplace, has named Tracy Denny ... newly created role, Denny will be responsible for ... business development function to include business development personnel ... strategies to achieve the firm’s strategic growth objectives. ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2
... YORK, Jan. 7 The American Stock Exchange ... the common,stock (the "Securities") of Samaritan Pharmaceuticals, Inc. ... on Form 25 to strike the Securities,from listing ... The,delisting will become effective on January 17, 2008 ...
... 7 Boston Scientific,Corporation (NYSE: BSX ) today ... affirmed a District Court ruling which found that the,NIR(R) ... Johnson & Johnson.,The Appeals Court also reversed the District ... the infringement of that claim. The Appeals,Court remanded the ...
... Science (CCTS) has announced the recipients of its 2008 ... $25,000 from the center to fund early studies in ... trials. The CCTS and the grant program are in ... and Translational Science Award the university received from the ...
... problems surfaced in people with no history of heart ... with no history of heart problems who felt extremely ... heart problems in the three years following the attacks, ... an immediate lethal heart attack in some people, it ...
... Jan. 7 ReBuilder,Medical Technologies, Inc. (Pink Sheets: ... Award. RBRM,s President, David B.,Phillips, Ph.D., was selected ... Award, produced by William Shatner. The initial public ... 2008. Dr. Phillips was,selected because of his state ...
... Blades, Inc. and its,medical device division IncisionTech announced ... Sons, Inc. The acquisition of Popper, a leading,specialty ... the combined company the leading contract manufacturer of ... Specialty Blades,originally announced its intention to acquire Popper ...
Cached Medicine News:Health News:Boston Scientific Announces Court Decision 2Health News:Rockefeller University's Center for Clinical and Translational Science funds pilot studies 2Health News:High Levels of Stress After 9/11 Raised Heart Disease Risk 2Health News:High Levels of Stress After 9/11 Raised Heart Disease Risk 3Health News:ReBuilder Medical Technologies, Inc. Announces Televised Broadcast 2
Scoville Ruptured Disc Curettes, length 10" (254 mm), cup size 4 x 10 mm....
PG Magnum Ring Curettes, total length 12.6" (32 cm), handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm), dual-coned, precision sharpened rings....
XL Cervical Curette comes with a bayonet design and satin black handles having instrument length 9.5" (24 cm), working distance4.1" (10.4 cm) and handle width 0.6" (1.5 cm)....
Bone Curette, 160 mm...
Medicine Products: